 Home > Medical News > Medical World News > Pharmaceutical giant Than Shwe and Shoreline form an alliance to accelerate the future application of cell therapy

Pharmaceutical giant Than Shwe and Shoreline form an alliance to accelerate the future application of cell therapy

 Last Update: 2021-11-12
 Source: Internet
 Author: User

Tags

keytruda drug

drug substance drug product

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 4th, U.

Dendreon is a commercial biopharmaceutical company and a leader in the development of cellular immunotherapy

The cooperation between the two biomedical giants can be described as a strong combination.

"In the field of cell therapy production, Dan Shing has more than ten years of mature and reliable professional knowledge, supply chain and logistics infrastructure, and will provide Shoreline with strong support from Phase I clinical trials to commercial cell production.

"Senior Vice President and CMC Director of Shoreline, Dr.

Cellular immunotherapy will play an increasingly prominent role in the future era of precision medicine, and it is expected to become a revolution in the field of tumor treatment following surgery, chemotherapy, radiotherapy and targeted therapy

About Than Shwe

American Than Shwe Biopharmaceutical Co.

About Shoreline Biotechnology Co.

Disclaimer: The market is risky, so choose carefully! This article is for reference only, not as a basis for trading

Y medicine officially landed! Jiahui International Cancer Center has become a pioneer in the use of dual immunotherapy in China

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pharmaceutical Intermediate API Raw Material 3,4-difluoro- CAS 2396750-32-4

CAS No.: 2396750-32-4

Industrial Grade

$700.00/G EXW

Catechol..

CAS No.: 120-80-9

Pharm grade

$1/MT FOB

1,1-Diphenylethylene.

CAS No.: 530-48-3

Pharmacy Grade

$1/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.